(Total Views: 234)
Posted On: 04/22/2022 12:10:54 PM
Post# of 104864
Avalon GloboCare Corp (NASDAQ: $AVCO ) is expanding its cellular immuno-oncology program with the addition of novel Chimeric Antigen Receptor – Natural Killer (CAR-NK) cell therapies. https://finance.yahoo.com/news/avalon-globoca...21173.html
(0)
(0)
Scroll down for more posts ▼
